Industrial Alliance Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Industrial Alliance Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-96,712	Closed	-$5.99M	–	481
2022 Q3	$5.99M	Sell	96,712 -60,670	-39%	-$4.24M	0.18%	128
2022 Q2	$12.6M	Buy	157,382 +24,820	+19%	+$2.35M	0.36%	72
2022 Q1	$14M	Sell	132,562 -36,870	-22%	-$3.59M	0.33%	72
2021 Q4	$18.3M	Buy	+169,432	New	+$18.5M	0.42%	54

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Industrial Alliance Investment Management's HZNP Position: Q4 2022 in Review

Industrial Alliance Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 96,712 shares — an estimated $5.99M sold.

Industrial Alliance Investment Management first reported a position in HZNP in Q4 2021 and held it in 4 quarters. The position peaked at $18.3M in Q4 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Industrial Alliance Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Industrial Alliance Investment Management sold 96,712 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $5.99M.
Industrial Alliance Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 4 quarters.
Industrial Alliance Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $18.3M in Q4 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Industrial Alliance Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.